Targeting <i>Toxoplasma gondii</i> ME49 TgAPN2: A Bioinformatics Approach for Antiparasitic Drug Discovery
As fewer therapeutic options are available for treating toxoplasmosis, newer antiparasitic drugs that can block TgAPN2 M1 aminopeptidase are of significant value. Herein, we employed several computer-aided drug-design approaches with the objective of identifying drug molecules from the Asinex librar...
Main Author: | Ali Altharawi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/7/3186 |
Similar Items
-
Genetic Disruption of <i>Toxoplasma gondii</i> <i>peroxiredoxin</i> (<i>TgPrx</i>) 1 and 3 Reveals the Essential Role of <i>TgPrx3</i> in Protecting Mice from Fatal Consequences of Toxoplasmosis
by: Ragab M. Fereig, et al.
Published: (2022-03-01) -
<i>Toxoplasma gondii</i> in Foods: Prevalence, Control, and Safety
by: Pablo-Jesús Marín-García, et al.
Published: (2022-08-01) -
Seroprevalence of <i>Toxoplasma gondii</i> in Slaughtered Pigs in Kiambu, Kenya
by: Dorcas Chepyatich, et al.
Published: (2023-10-01) -
Toxoplasmose ocular em cães jovens inoculados com Toxoplasma gondii Ocular toxoplasmosis in young dogs inoculated with Toxoplasma gondii
by: Cláudia Bonini de Abreu, et al.
Published: (2002-10-01) -
Sero-epidemiological Study of Toxoplasma gondii among Pregnant Women in Akre City
by: Hogir Mohammed Shukri Saadi, et al.
Published: (2020-12-01)